BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22512667)

  • 41. Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report.
    van der Laan JW; Chapin RE; Haenen B; Jacobs AC; Piersma A
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):115-23. PubMed ID: 22449444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a testing strategy for detecting embryotoxic hazards of chemicals in vitro by using embryonic stem cell models.
    Bremer S; Pellizzer C; Adler S; Paparella M; de Lange J
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():107-9. PubMed ID: 12513659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity.
    Peters AK; Wouwer GV; Weyn B; Verheyen GR; Vanparys P; Gompel JV
    Toxicol In Vitro; 2008 Dec; 22(8):1948-56. PubMed ID: 18845236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
    Stummann TC; Hareng L; Bremer S
    Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A statistical approach towards the derivation of predictive gene sets for potency ranking of chemicals in the mouse embryonic stem cell test.
    Schulpen SH; Pennings JL; Tonk EC; Piersma AH
    Toxicol Lett; 2014 Mar; 225(3):342-9. PubMed ID: 24480513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of the embryonic stem cell test endpoint analysis by use of field potential detection.
    Koseki N; Deguchi J; Yamada T; Funabashi H; Seki T
    J Toxicol Sci; 2010 Oct; 35(5):619-29. PubMed ID: 20930457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary cell and micromass culture in assessing developmental toxicity.
    Pratten M; Ahir BK; Smith-Hurst H; Memon S; Mutch P; Cumberland P
    Methods Mol Biol; 2012; 889():115-46. PubMed ID: 22669663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Establishment of embryonic stem cell for evaluation of development neurotoxicity and test the validation of embryonic stem cell].
    Yu Z; Xu H
    Wei Sheng Yan Jiu; 2010 Nov; 39(6):685-8. PubMed ID: 21351631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test.
    Seiler AE; Buesen R; Visan A; Spielmann H
    Methods Mol Biol; 2006; 329():371-95. PubMed ID: 16846005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Embryotoxicity assessment of developmental neurotoxicants using a neuronal endpoint in the embryonic stem cell test.
    Baek DH; Kim TG; Lim HK; Kang JW; Seong SK; Choi SE; Lim SY; Park SH; Nam BH; Kim EH; Kim MS; Park KL
    J Appl Toxicol; 2012 Aug; 32(8):617-26. PubMed ID: 22131109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
    Dent MP
    Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Development of prediction models for three in vitro embryotoxicity tests which are evaluated in an ECVAM validation study].
    Genschow E; Scholz G; Brown NA; Piersma AH; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Spielmann H
    ALTEX; 1999; 16(2):73-83. PubMed ID: 11107310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment of a molecular embryonic stem cell developmental toxicity assay.
    Panzica-Kelly JM; Brannen KC; Ma Y; Zhang CX; Flint OP; Lehman-McKeeman LD; Augustine-Rauch KA
    Toxicol Sci; 2013 Feb; 131(2):447-57. PubMed ID: 23042729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes.
    van Dartel DA; Pennings JL; de la Fonteyne LJ; van Herwijnen MH; van Delft JH; van Schooten FJ; Piersma AH
    Toxicol Sci; 2010 Jul; 116(1):130-9. PubMed ID: 20421339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of embryotoxicity of compounds in cosmetics by the embryonic stem cell test.
    Chen R; Chen J; Cheng S; Qin J; Li W; Zhang L; Jiao H; Yu X; Zhang X; Lahn BT; Xiang AP
    Toxicol Mech Methods; 2010 Mar; 20(3):112-8. PubMed ID: 20100057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests.
    Piersma AH; Genschow E; Verhoef A; Spanjersberg MQ; Brown NA; Brady M; Burns A; Clemann N; Seiler A; Spielmann H
    Altern Lab Anim; 2004 Sep; 32(3):275-307. PubMed ID: 15588168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The way forward in reproductive/developmental toxicity testing.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro embryotoxicity testing of metals for dental use by differentiation of embryonic stem cell test.
    Imai K; Nakamura M
    Congenit Anom (Kyoto); 2006 Mar; 46(1):34-8. PubMed ID: 16643597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The validated embryonic stem cell test to predict embryotoxicity in vitro.
    Seiler AE; Spielmann H
    Nat Protoc; 2011 Jun; 6(7):961-78. PubMed ID: 21720311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.